Telehealth-only GLP-1 programs have genuinely expanded access to semaglutide and tirzepatide for many patients who would not otherwise have been able to start therapy. That is a real and meaningful benefit, and this article is not dismissing telehealth categorically.
The question is what you get in return for lower-cost, lower-touch care — and what you give up. For patients in San Antonio, Boerne, and the surrounding Hill Country area, a full physician-supervised clinic is accessible. Understanding the clinical differences between the two models helps you make an informed decision about your medical weight loss program.
What Telehealth-Only GLP-1 Programs Typically Include
Telehealth-only GLP-1 programs operate primarily through online questionnaires and remote physician sign-off. The typical structure:
- Online health questionnaire — not an in-person physician evaluation; you answer questions about your health history through a web form or app
- Physician sign-off without meeting the patient — a physician reviews your questionnaire responses and, if criteria are met, approves the prescription remotely; the patient typically does not speak with or meet this physician
- Prescription sent to mail-order pharmacy — medication shipped to your home; no on-site dispensing or in-person pharmacist consultation
- Limited or no ongoing monitoring — some programs include periodic check-ins through a patient portal; many have no structured mechanism for dose adjustment based on clinical response
FTC pricing note: In December 2025, the FTC issued a final enforcement order against a telehealth GLP-1 provider for advertising monthly membership prices that excluded medication, lab, and consultation costs — the actual total cost was substantially higher than advertised. When evaluating any GLP-1 program, ask: does the advertised price include medication, labs, and monitoring? An honest program answers that question directly.
What a Local Physician-Supervised Program Includes
An in-person physician clinic begins with a face-to-face consultation. This is a full clinical encounter — the prescribing physician reviews your health history, current medications, prior weight loss attempts, and weight-related health conditions in person, before any prescription decision is made.
The clinical difference at this stage matters: a physician evaluating you in person has access to information a questionnaire cannot capture — your presentation, any physical findings relevant to the prescribing decision, and the ability to ask follow-up questions before committing to a protocol.
At Vitality Texas, the full physician-supervised program includes:
- In-person consultation with Dr. Jamie Lynn Jaqua, MD — the prescribing physician, not a portal interface
- On-site baseline lab draw — blood drawn at your first visit, processed on-site with results available the following day; no mail kit, no shipping delay
- Physician-reviewed labs before prescribing — Dr. Jaqua reviews your actual lab values; contraindications are identified before any medication is started
- Physician-managed dose titration — dosing adjusted based on your response at each follow-up visit, not on a preset escalation schedule
- Direct physician access — follow-up questions and side effect management go directly to the clinic, not through a patient portal queue
The Medical Risk of Prescribing Without Labs
GLP-1 medications are not appropriate for every patient. Specific contraindications include:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- History of serious hypersensitivity reaction to semaglutide or tirzepatide
- Prior pancreatitis — baseline labs that include pancreatic enzymes help identify relevant history
- Severe kidney disease — GLP-1 medications require dose consideration in patients with significantly impaired renal function
None of these contraindications are reliably detectable through a self-reported online questionnaire. Baseline HbA1c identifies unmanaged diabetes before prescribing — a clinically significant finding that affects how GLP-1 therapy is initiated and monitored. Physician-reviewed labs are the safety gate, not a formality or an add-on cost.
Thyroid and metabolic panels done before prescribing also establish the baseline against which response is measured. Without a baseline, there is no objective metric for evaluating whether the treatment is working or whether a clinical issue is emerging.
FTC Warning: Pricing Transparency in Online GLP-1 Programs
In December 2025, the FTC issued a final enforcement order against a telehealth GLP-1 provider for advertising a low monthly membership price that excluded medication cost, lab cost, and consultation cost. The actual total cost was substantially higher than the advertised price. The FTC found this to be a deceptive practice under Section 5 of the FTC Act.
This enforcement action reflects a pattern in the telehealth GLP-1 market: advertised prices that lead with a low headline number while burying the full cost of medication and required clinical components. When evaluating any GLP-1 program — telehealth or in-person — ask explicitly: does the advertised price include medication, labs, initial consultation, and follow-up monitoring? A provider who answers that question directly and completely is behaving transparently. One who defers or provides vague answers to cost questions is not.
The Monitoring Gap — When Things Go Wrong
GLP-1 therapy during the dose titration phase is the period of greatest clinical variability. Side effects are most common in the first weeks of treatment as doses escalate. Patients who do not respond as expected — insufficient weight loss, plateau earlier than anticipated, or problematic side effects — need physician guidance to adjust the protocol.
In a telehealth-only program with limited monitoring, the mechanism for addressing these situations is often inadequate: portal messages, scheduled check-ins at fixed intervals, or no structured mechanism at all. Dose adjustment requires physician judgment — determining whether the issue is dose timing, rate of escalation, medication choice, or a co-existing factor (such as testosterone deficiency in men, which can independently impair weight loss response) is a clinical evaluation, not a portal interaction.
At Vitality Texas, when something changes in your response or you experience side effects, your follow-up is with Dr. Jaqua directly — not routed through a patient portal to a different provider each time. The physician who established your care manages your ongoing protocol.
Why Some Patients Choose Telehealth — And When It Makes Sense
Telehealth-only GLP-1 programs are not categorically wrong. There are clinical situations where they represent a reasonable access option:
- Rural access — patients in areas without a physician-supervised clinic within reasonable driving distance face a genuine access problem; telehealth provides care where no in-person option exists
- Established stable patients — patients who have been on a stable GLP-1 protocol for an extended period, understand their labs, and have no active clinical concerns may find telehealth follow-up reasonable as a maintenance option
For patients in San Antonio, Boerne, Helotes, Stone Oak, and the surrounding I-10 corridor, a physician-supervised clinic is accessible. Using a telehealth-only program when an in-person option is 20 to 30 minutes away involves real trade-offs for a convenience benefit that is less compelling when the clinic is accessible.
The Vitality Difference in San Antonio
The specific structural advantages of Vitality Texas are factual and verifiable:
- Dr. Jaqua, MD — the prescribing physician is a medical doctor; patients are evaluated and monitored by the same physician who established their care
- On-site labs with next-day results — no mail kits, no shipping, no national lab queue; blood drawn at your visit is processed on-site
- Physician dose management — titration is based on your actual clinical response at each visit, not a preset escalation schedule
- Metabolic health evaluation beyond weight — Dr. Jaqua evaluates thyroid, metabolic panel, and hormonal factors that independently affect weight loss response; for male patients, this includes testosterone evaluation
- Physical location: 28711 I-10, Boerne, TX 78006 — serving San Antonio, Boerne, and the greater I-10 corridor
For context on how physician-supervised care compares across treatment types, see similarly, physician-supervised TRT involves the same principles of in-person evaluation and lab-based protocol management.
Frequently Asked Questions
Is telehealth GLP-1 safe?
Telehealth GLP-1 programs can be appropriate in certain situations — particularly for patients in rural areas without access to a local physician clinic. The key safety variable is whether a licensed physician reviews your health history and lab results before prescribing. GLP-1 medications have real contraindications (certain thyroid conditions, MEN2 history, prior pancreatitis, severe kidney disease) that require a physician evaluation to identify. A telehealth program that completes lab work before prescribing and maintains physician oversight for dosing is meaningfully different from one that prescribes based on a questionnaire alone. Not all telehealth programs are equivalent — the depth of physician involvement varies significantly.
Why does a local clinic cost more than an online program?
Local clinics typically include components that many online programs do not: in-person physician consultation, on-site lab draw with next-day results, physician-reviewed labs before prescribing, and direct physician access for dose adjustments and side effect management. These components add cost — and they represent real clinical value, particularly during the dose titration phase when physician judgment matters most. Online programs often advertise lower headline prices that reflect medication cost alone, without labs or monitoring. When you compare total program cost across 12 months — including all components — the gap between online and in-person programs often narrows. The FTC has taken enforcement action against providers who advertise incomplete program prices; always ask what a quoted price includes.
Does Vitality offer any remote or telehealth options?
Vitality Texas requires an in-person initial consultation and lab draw — this is a standard-of-care requirement for responsible GLP-1 prescribing. A physician must review your labs in person before writing a prescription for a GLP-1 medication. After your initial evaluation, follow-up management may involve fewer in-person visits depending on your treatment progress and protocol. Patients who are stable on a well-established protocol may have longer intervals between in-person visits. For patients from the greater San Antonio area, the initial in-person visit at our Boerne clinic is typically a single appointment at which consultation and lab draw occur on the same day.
Conclusion
The choice between a telehealth-only GLP-1 program and an in-person physician clinic is a real clinical decision — not just a cost comparison. What each model includes, how contraindications are identified, how dosing is managed, and what happens when something changes in your response are all structural differences with meaningful clinical consequences.
For patients in the San Antonio and Boerne area, physician-supervised care is accessible. At Vitality Texas, your free initial consultation includes a full physician evaluation and lab draw — everything required to make an informed prescribing decision before treatment begins. Visit our medical weight loss program page to learn more or to request a free consultation.
References
- FTC. In the Matter of Mochi Health, Inc. d/b/a NextMed: Final Order. FTC Docket No. C-4845. December 2025. FTC.gov.
- FDA. Prescribing Information: Wegovy (semaglutide) injection. Novo Nordisk. 2021.
- FDA. Prescribing Information: Zepbound (tirzepatide) injection. Eli Lilly and Company. 2023.